IBM and Pfizer Believe Machine Learning Can Predict Alzheimer’s RiskAlzheimer’s Risk, Analysis, Artificial Intelligence, Biomarkers, Data, Machine Learning, National Institutes of Health, Studies, The Lancet eClinicalMedicine, U.S. Alzheimer’s AssociationResearchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict the eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample. Read more October 23, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/10/IBM-and-Pfizer-Believe-Machine-Learning-Can-Predict-Alzheimer’s-Risk-BioSpace-10-23-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-10-23 11:37:572020-10-25 18:21:29IBM and Pfizer Believe Machine Learning Can Predict Alzheimer’s Risk